Clinical Trial Design for Non-Muscle Invasive Bladder Cancer

U.S. Food and Drug Administration

The purpose of this workshop is to discuss challenges and opportunities in clinical trial design for patients with NMIBC.

ABOUT THE PUBLIC WORKSHOPThe U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) and Center for Drug Evaluation and Research (CDER) welcome you to this FDA Virtual Public Workshop: Clinical Trial Design for Non-Muscle Invasive Bladder Cancer (NMIBC). The purpose of this workshop is to discuss challenges and opportunities in clinical trial design for patients with NMIBC. The ultimate goal of the workshop is to identify actionable next steps towards facilitating feasible trial designs that can capture interpretable and clinically meaningful results.Sessions 1-3 are on the first day of the workshop (Thursday, November 18th).<ul><li>The first two sessions will cover the BCG shortage, impact on clinical practice, and implications for trial design for the BCG-naïve population.</li><li>The third session will focus on trial design in the BCG-unresponsive population and potential trial designs with cystectomy-free survival as a secondary endpoint.</li></ul>Sessions 4-6 will be on the second day of the workshop (Friday, November 19th).<ul><li>Sessions 4 and 5 will cover issues related to trial design for the two distinct classifications of NMIBC; i.e., carcinoma in situ and papillary disease.</li><li>Session 6 will focus on capturing the patients’ perspective in trial design including experiences, needs, and priorities.</li></ul>Workshop moderators and panelists include regulators, urologists, medical oncologists, and patients. We look forward to productive discussions during this workshop.Meeting Goals<ul><li>Provide a forum for open discussion between academia, international regulators, and patient advocacy groups to advance clinical trial design in NMIBC;</li><li>Develop greater precision around NMIBC disease states to facilitate the rational design of and appropriate patient selection for clinical trials in NMIBC;</li><li>Identify questions that would benefit from further study; and</li><li>Envision novel designs and endpoints for future trials.</li></ul>REGISTRATION AND CHECK-INInterested parties are encouraged to register early. Registration is required for online attendance and will be available until noon on November 19th, 2021.MEETING MATERIALSA final agenda will be available one week before the workshop.Please visit the <a href="https://www.fda.gov/drugs/news-events-human-drugs/clinical-trial-design-non-muscle-invasive-bladder-cancer-nmibc-11182021-11192021" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">workshop web page</a> for additional information. ONLINE ATTENDANCEThis meeting will be available for online viewing, on the day of the meeting via the following link: <a href="https://fda.zoomgov.com/j/1602905396?pwd=YTdjejEzY0hhZUNwenJWak9Jd0M2QT09" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">https://fda.zoomgov.com/j/1602905396?pwd=YTdjejEzY0hhZUNwenJWak9Jd0M2QT09</a> | Passcode: 7Ec#AjRegistered attendees will receive an email on November 17th, 2021 detailing how to join the webcast. EVENT POINT OF CONTACTJoan Ferlo Todd, RN, MSSenior Regulatory Health Project ManagerOncology Center of Excellence, (OCE)Office of the Commissioner (OC)U.S. Food and Drug Administration10903 New Hampshire Ave, Silver Spring, MD 20993Tel: 301.796.6079Joan.Todd@fda.hhs.govCaitlin Drew, MSN, RNSenior Regulatory Health Project ManagerOncology Center of Excellence, (OCE)Office of the Commissioner (OC)U.S. Food and Drug Administration10903 New Hampshire Ave, Silver Spring, MD 20993Tel: 301.318.8609Caitlin.Drew@fda.hhs.gov

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}

Clinical Trial Design for Non-Muscle Invasive Bladder Cancer

More events from U.S. Food and Drug Administration

Discover more events from U.S. Food and Drug Administration, from Health to other experiences you might love.

Still looking for the right event?

Explore all online events to browse and filter by date, category, and more.

Clinical Trial Design for Non-Muscle Invasive Bladder Cancer

More events from U.S. Food and Drug Administration

Discover more events from U.S. Food and Drug Administration, from Health to other experiences you might love.

More Health events

Browse more Health events with different dates, prices, and formats to find your next great experience.

Still looking for the right event?

Explore all online events to browse and filter by date, category, and more.